drugset / Trial / NCT05494164

Nigella Sativa for Selected Outcomes in Chronic Rhinosinusitis

NCT05494164

Completed 102 enrolled Cairo University
RandomizedParallel-groupSingle-blindTreatment

Summary

the study is intended to test the effect of Nigella sativa nasal oil drops on selected outcomes among patients with chronic rhinosinusitis using prospective clinical trial design. To achieve the aim of the current trial the following research hypotheses are postulated: H1. The total severity of symptoms mean scores of patients with CRS who will use Nigella sativa nasal oil drops will be different from the total severity of symptoms mean scores of a control group. H2. The total sleep quality mean scores of patients with CRS who will use Nigella sativa nasal oil drops will be different from the total sleep quality mean scores of a control group. H3. The total patient satisfaction mean scores of patients with CRS who will use Nigella sativa nasal oil drops will be different from the total patient satisfaction mean scores of a control group.

Timeline

Start
2022-08-07
Primary completion
2023-05-23
Completion
2023-05-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Nigella sativa Traditional medicine (herbal / TCM) 100 mg Intranasal